Ad
related to: alternatives to armodafinil 20 gram solution for humans review new york times- 109 S High St #100, Columbus, OH · Directions · (614) 224-4261
- Lab Tests Made Simple
Let us do the hard work for you. We
offer convenient online lab tests.
- Transparent Pricing
Healthcare is confusing. We make it
simple. Use GoodRx to start saving.
- Visit Our FAQs
Have Questions? We've Got Answers.
See Our FAQs to Learn More Now!
- Research You Can Rely On
Our team works hard to provide you
with the latest healthcare info.
- Lab Tests Made Simple
Search results
Results from the WOW.Com Content Network
Chemical structure of modafinil.. This page lists chemical compounds similar to modafinil, known as modafinil analogues and derivatives.These are structural analogues and derivatives of modafinil, a drug that affects dopamine levels in the brain in an unusual way (atypical dopamine reuptake inhibitor or DRI).
Eugeroics, in the sense of modafinil-type wakefulness promoting agents, include modafinil itself, armodafinil, and adrafinil, among others. [9] They are medically indicated for the treatment of certain sleep disorders , including excessive daytime sleepiness (EDS) in narcolepsy or obstructive sleep apnea (OSA).
Elevated mood occurred in 2.4% with placebo, 8 to 24% with solriamfetol, and 10 to 18% with phentermine, while feelings of relaxation occurred in 5% with placebo, 5 to 19% with solriamfetol, and 15 to 20% with phentermine. [1] As such, solriamfetol has significant misuse potential and is a controlled substance in the United States. [1]
Unlike armodafinil ((R)-(–)-modafinil), esmodafinil has never been marketed on its own. [ 3 ] Esmodafinil is suspected to be less clinically useful for treating conditions that modafinil and armodafinil are marketed for, such as narcolepsy , shift work sleep disorder , and obstructive sleep apnea .
Fladrafinil (developmental code name CRL-40,941), also known as fluorafinil or as bisfluoroadrafinil, is a wakefulness-promoting agent related to modafinil that was never marketed.
Flmodafinil (developmental code names CRL-40,940, NLS-4, JBG01-41), also known as bisfluoromodafinil and lauflumide, is a wakefulness-promoting agent related to modafinil which has been developed for treatment of a variety of different medical conditions.
At steady state, the systemic exposure for armodafinil is 1.8 times the exposure observed after a single dose. The concentration-time profiles of the ( R )-(−)-enantiomer following a single dose of 50 mg Nuvigil or 100 mg Provigil (modafinil being a 1:1 mixture of ( R )-(−)- and ( S )-(−)- enantiomers) are nearly superimposable.
The substance was first tested in humans, specifically for the treatment of narcolepsy, in 1977–1978. [18] Introduced by Lafon (now Cephalon), it reached the market in France in 1984, [7] and for the treatment of narcolepsy in 1985. [18] [19] In 1976, two years after the discovery of adrafinil, its active metabolite modafinil was discovered. [18]
Ad
related to: alternatives to armodafinil 20 gram solution for humans review new york times- 109 S High St #100, Columbus, OH · Directions · (614) 224-4261
